Henju Marjuki1, Vasiliy P Mishin1, Anton P Chesnokov2, Joyce Jones1, Juan A De La Cruz2, Katrina Sleeman1, Daisuke Tamura3, Ha T Nguyen2, Ho-Sheng Wu4, Feng-Yee Chang4, Ming-Tsan Liu4, Alicia M Fry1, Nancy J Cox1, Julie M Villanueva1, Charles T Davis1, Larisa V Gubareva5. 1. Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. 2. Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Battelle Memorial Institute, Atlanta, Georgia. 3. Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Oak Ridge Institute for Science and Education, Tennessee. 4. Taiwan Centers for Disease Control, Taipei City. 5. Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention lgubareva@cdc.gov.
Abstract
BACKGROUND: Patients contracting influenza A(H7N9) infection often developed severe disease causing respiratory failure. Neuraminidase (NA) inhibitors (NAIs) are the primary option for treatment, but information on drug-resistance markers for influenza A(H7N9) is limited. METHODS: Four NA variants of A/Taiwan/1/2013(H7N9) virus containing a single substitution (NA-E119V, NA-I222K, NA-I222R, or NA-R292K) recovered from an oseltamivir-treated patient were tested for NAI susceptibility in vitro; their replicative fitness was evaluated in cell culture, mice, and ferrets. RESULTS: NA-R292K led to highly reduced inhibition by oseltamivir and peramivir, while NA-E119V, NA-I222K, and NA-I222R caused reduced inhibition by oseltamivir. Mice infected with any virus showed severe clinical signs with high mortality rates. NA-I222K virus was the most virulent in mice, whereas virus lacking NA change (NA-WT) and NA-R292K virus seemed the least virulent. Sequence analysis suggests that PB2-S714N increased virulence of NA-I222K virus in mice; NS1-K126R, alone or in combination with PB2-V227M, produced contrasting effects in NA-WT and NA-R292K viruses. In ferrets, all viruses replicated to high titers in the upper respiratory tract but produced only mild illness. NA-R292K virus, showed reduced replicative fitness in this animal model. CONCLUSIONS: Our data highlight challenges in assessment of the replicative fitness of H7N9 NA variants that emerged in NAI-treated patients.
BACKGROUND:Patientscontracting influenza A(H7N9) infection often developed severe disease causing respiratory failure. Neuraminidase (NA) inhibitors (NAIs) are the primary option for treatment, but information on drug-resistance markers for influenza A(H7N9) is limited. METHODS: Four NA variants of A/Taiwan/1/2013(H7N9) virus containing a single substitution (NA-E119V, NA-I222K, NA-I222R, or NA-R292K) recovered from an oseltamivir-treated patient were tested for NAI susceptibility in vitro; their replicative fitness was evaluated in cell culture, mice, and ferrets. RESULTS: NA-R292K led to highly reduced inhibition by oseltamivir and peramivir, while NA-E119V, NA-I222K, and NA-I222R caused reduced inhibition by oseltamivir. Mice infected with any virus showed severe clinical signs with high mortality rates. NA-I222K virus was the most virulent in mice, whereas virus lacking NA change (NA-WT) and NA-R292K virus seemed the least virulent. Sequence analysis suggests that PB2-S714N increased virulence of NA-I222K virus in mice; NS1-K126R, alone or in combination with PB2-V227M, produced contrasting effects in NA-WT and NA-R292K viruses. In ferrets, all viruses replicated to high titers in the upper respiratory tract but produced only mild illness. NA-R292K virus, showed reduced replicative fitness in this animal model. CONCLUSIONS: Our data highlight challenges in assessment of the replicative fitness of H7N9 NA variants that emerged in NAI-treated patients.
Authors: Hui-Ling Yen; Jie Zhou; Ka-Tim Choy; Sin Fun Sia; Ooiean Teng; Iris H Ng; Vicky J Fang; Yunwen Hu; Wei Wang; Benjamin J Cowling; John M Nicholls; Yi Guan; Joseph Sriyal Malik Peiris Journal: J Infect Dis Date: 2014-06-20 Impact factor: 5.226
Authors: Chris Ka Pun Mok; Horace Hok Yeung Lee; Maxime Lestra; John Malcolm Nicholls; Michael Chi Wai Chan; Sin Fun Sia; Huachen Zhu; Leo Lit Man Poon; Yi Guan; Joseph Sriyal Malik Peiris Journal: J Virol Date: 2014-01-08 Impact factor: 5.103
Authors: Christopher W Seibert; Michael Kaminski; Jennifer Philipp; Dennis Rubbenstroth; Randy A Albrecht; Folker Schwalm; Silke Stertz; Rafael A Medina; Georg Kochs; Adolfo García-Sastre; Peter Staeheli; Peter Palese Journal: J Virol Date: 2010-08-25 Impact factor: 5.103
Authors: Philippe Simon; Benjamin P Holder; Xavier Bouhy; Yacine Abed; Catherine A A Beauchemin; Guy Boivin Journal: J Clin Microbiol Date: 2010-11-24 Impact factor: 5.948
Authors: Rong Hai; Mirco Schmolke; Victor H Leyva-Grado; Rajagowthamee R Thangavel; Irina Margine; Eric L Jaffe; Florian Krammer; Alicia Solórzano; Adolfo García-Sastre; Peter Palese; Nicole M Bouvier Journal: Nat Commun Date: 2013 Impact factor: 14.919
Authors: Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Juan A De La Cruz; Charles T Davis; Julie M Villanueva; Alicia M Fry; Larisa V Gubareva Journal: J Virol Date: 2015-03-04 Impact factor: 5.103
Authors: Dan Yan; Marco Weisshaar; Kristen Lamb; Hokyung K Chung; Michael Z Lin; Richard K Plemper Journal: Biochemistry Date: 2015-09-01 Impact factor: 3.162
Authors: Ju Hwan Jeong; Won-Suk Choi; Khristine Joy C Antigua; Young Ki Choi; Elena A Govorkova; Richard J Webby; Yun Hee Baek; Min-Suk Song Journal: J Virol Date: 2020-12-09 Impact factor: 5.103